Anzahl der Publikationen: 5
Zeitschriftenartikel
Ott, Oliver J.; Gani, Cihan; Lindner, Lars H.; Schmidt, Manfred; Lamprecht, Ulf; Abdel-Rahman, Sultan; Hinke, Axel; Weissmann, Thomas; Hartmann, Arndt; Issels, Rolf D.; Zips, Daniel; Belka, Claus; Grutzmann, Robert und Fietkau, Rainer
(2021):
Neoadjuvant Chemoradiation Combined with Regional Hyperthermia in Locally Advanced or Recurrent Rectal Cancer.
In: Cancers, Bd. 13, Nr. 6, 1279
Lueong, Smiths S.; Herbst, Andreas; Liffers, Sven-Thorsten; Bielefeld, Nicola; Horn, Peter A.; Tannapfel, Andrea; Reinacher-Schick, Anke; Hinke, Axel; Hegewisch-Becker, Susanna; Kolligs, Frank T. und Siveke, Jens T.
(2020):
Serial Circulating Tumor DNA Mutational Status in Patients with KRAS-Mutant Metastatic Colorectal Cancer from the Phase 3 AIO KRK0207 Trial.
In: Clinical Chemistry, Bd. 66, Nr. 12: S. 1510-1520
Straka, Christian; Liebisch, Peter; Salwender, Hans; Hennemann, Burkhard; Metzner, Bernd; Knop, Stefan; Adler-Reichel, Sigrid; Gerecke, Christian; Wandt, Hannes; Bentz, Martin; Bruemmendorf, Tim Hendrik; Hentrich, Marcus; Pfreundschuh, Michael; Wolf, Hans-Heinrich; Sezer, Orhan; Bargou, Ralf; Jung, Wolfram; Truemper, Lorenz; Hertenstein, Bernd; Heidemann, Else; Bernhard, Helga; Lang, Nicola; Frickhofen, Norbert; Hebart, Holger; Schmidmaier, Ralf; Sandermann, Andreas; Dechow, Tobias; Reichle, Albrecht; Schnabel, Brigitte; Schäfer-Eckart, Kerstin; Langer, Christian; Gramatzki, Martin; Hinke, Axel; Emmerich, Bertold und Einsele, Hermann
(2016):
Autotransplant with and without induction chemotherapy in older multiple myeloma patients: long-term outcome of a randomized trial.
In: Haematologica, Bd. 101, Nr. 11: S. 1398-1406
Giessen, Clemens; Fischer von Weikersthal, Ludwig; Hinke, Axel; Stintzing, Sebastian; Kullmann, Frank; Vehling-Kaiser, Ursula; Mayerle, Julia; Bangerter, Markus; Denzlinger, Claudio; Sieber, Markus; Teschendorf, Christian; Freiberg-Richter, Jens; Schulz, Christoph; Modest, Dominik Paul; Moosmann, Nicolas; Aubele, Philipp und Heinemann, Volker
(2011):
A randomized, phase III trial of capecitabine plus bevacizumab (Cape-Bev) versus capecitabine plus irinotecan plus bevacizumab (CAPIRI-Bev) in first-line treatment of metastatic colorectal cancer: The AIO KRK 0110 Trial/ML22011 Trial.
In: BMC Cancer
11:367
[PDF, 533kB]
Diese Liste wurde am
Sat Dec 21 18:40:10 2024 CET
erstellt.